{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:43:28Z","timestamp":1790739808593,"version":"4.1.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2019,6,29]],"date-time":"2019-06-29T00:00:00Z","timestamp":1561766400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,6,29]],"date-time":"2019-06-29T00:00:00Z","timestamp":1561766400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Neurol Neurosci Rep"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s11910-019-0966-3","type":"journal-article","created":{"date-parts":[[2019,6,29]],"date-time":"2019-06-29T08:02:36Z","timestamp":1561795356000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Recent Advancement and Clinical Implications of 18FDG-PET in Parkinson\u2019s Disease, Atypical Parkinsonisms, and Other Movement Disorders"],"prefix":"10.1007","volume":"19","author":[{"given":"Cecilia","family":"Peralta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Biafore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara Soto","family":"Depetris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Bastianello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,29]]},"reference":[{"issue":"2","key":"966_CR1","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/mds.26907","volume":"32","author":"AP Strafella","year":"2017","unstructured":"\u2022\u2022 Strafella AP, Bohnen NI, Perlmutter JS, Eidelberg D, Pavese N, Van Eimeren T, et al. Molecular imaging to track Parkinson\u2019s disease and atypical parkinsonisms: new imaging frontiers. Mov Disord. 2017;32(2):181\u201392. The authors provide an overview of molecular imaging advances in PD and AP, how these approaches help to their understanding and revise exciting new tracer developments.","journal-title":"Mov Disord"},{"issue":"10","key":"966_CR2","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.tins.2013.07.001","volume":"36","author":"P Mergenthaler","year":"2013","unstructured":"Mergenthaler P, Lindauer U, Dienel GA, Meisel A. Sugar for the brain: the role of glucose in physiological and pathological brain function. Trends Neurosci. 2013;36(10):587\u201397.","journal-title":"Trends Neurosci"},{"issue":"2","key":"966_CR3","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.neubiorev.2010.02.001","volume":"35","author":"S Ikemoto","year":"2010","unstructured":"Ikemoto S. Brain reward circuitry beyond the mesolimbic dopamine system: a neurobiological theory. Neurosci Biobehav Rev. 2010;35(2):129\u201350.","journal-title":"Neurosci Biobehav Rev"},{"key":"966_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-7091-6360-3_1","volume":"56","author":"KA Jellinger","year":"1999","unstructured":"Jellinger KA. Post mortem studies in Parkinson\u2019s disease\u2014is it possible to detect brain areas for specific symptoms? J Neural Transm Suppl. 1999;56:1\u201329.","journal-title":"J Neural Transm Suppl"},{"issue":"5","key":"966_CR5","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/jcbfm.1994.99","volume":"14","author":"D Eidelberg","year":"1994","unstructured":"Eidelberg D, Moeller JR, Dhawan V, Spetsieris P, Takikawa S, Ishikawa T, et al. The metabolic topography of parkinsonism. J Cereb Blood Flow Metab. 1994;14(5):783\u2013801.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"5","key":"966_CR6","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1093\/cercor\/bhp178","volume":"20","author":"RC Helmich","year":"2010","unstructured":"Helmich RC, Derikx LC, Bakker M, Scheeringa R, Bloem BR, Toni I. Spatial remapping of cortico-striatal connectivity in Parkinson\u2019s disease. Cereb Cortex. 2010;20(5):1175\u201386.","journal-title":"Cereb Cortex"},{"issue":"4","key":"966_CR7","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.pneurobio.2011.08.009","volume":"95","author":"DJ Brooks","year":"2011","unstructured":"Brooks DJ, Pavese N. Imaging biomarkers in Parkinson\u2019s disease. Prog Neurobiol. 2011;95(4):614\u201328.","journal-title":"Prog Neurobiol"},{"key":"966_CR8","doi-asserted-by":"publisher","first-page":"3575","DOI":"10.1002\/hbm.22863","volume":"36","author":"F Holtbernd","year":"2015","unstructured":"Holtbernd F, Ma Y, Peng S, Schwartz F, Timmermann L, Kracht L, et al. Dopaminergic correlates of metabolic network activity in Parkinson\u2019s disease. Hum Brain Mapp. 2015;36:3575\u201385.","journal-title":"Hum Brain Mapp"},{"issue":"12","key":"966_CR9","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.2967\/jnumed.115.156067","volume":"56","author":"O Granert","year":"2015","unstructured":"\u2022 Granert O, Drzezga AE, Boecker H, Perneczky R, Kurz A, G\u00f6tz J, et al. Metabolic topology of neurodegenerative disorders: influence of cognitive and motor deficits. J Nucl Med. 2015;56(12):1916\u201321. The study describes the important correlations between FDG-PET metabolic pattern and clinical measurements (cognitive AD-typical vs motor PD-typical pattern).","journal-title":"J Nucl Med"},{"key":"966_CR10","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1093\/brain\/awm086","volume":"130","author":"C Huang","year":"2007","unstructured":"Huang C, Tang C, Feigin A, Lesser M, Ma Y, Pourfar M, et al. Changes in network activity with the progression of Parkinson\u2019s disease. Brain. 2007;130(Pt 7:1834\u201346.","journal-title":"Brain"},{"issue":"9","key":"966_CR11","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1002\/mds.26302","volume":"30","author":"Y Ma","year":"2015","unstructured":"Ma Y, Johnston TH, Peng S, Zuo C, Koprich JB, Fox SH, et al. Reproducibility of a parkinsonism-related metabolic brain network in non-human primates: a descriptive pilot study with FDG PET. Mov Disord. 2015;30(9):1283\u20138.","journal-title":"Mov Disord"},{"issue":"2","key":"966_CR12","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nrn.2016.178","volume":"18","author":"DJ Surmeier","year":"2017","unstructured":"Surmeier DJ, Obeso JA, Halliday GM. Selective neuronal vulnerability in Parkinson disease. Nat Rev Neurosci. 2017;18(2):101\u201313.","journal-title":"Nat Rev Neurosci"},{"issue":"4","key":"966_CR13","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1002\/ana.1232","volume":"50","author":"PC Su","year":"2001","unstructured":"Su PC, Ma Y, Fukuda M, Mentis MJ, Tseng HM, Yen RF, et al. Metabolic changes following subthalamotomy for advanced Parkinson\u2019s disease. Ann Neurol. 2001;50(4):514\u201320.","journal-title":"Ann Neurol"},{"issue":"2","key":"966_CR14","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1159\/000455930","volume":"95","author":"C Cao","year":"2017","unstructured":"\u2022 Cao C, Zhang H, Li D, Zhan S, Zhang J, Zhang X, et al. Modified fluorodeoxyglucose metabolism in motor circuitry by subthalamic deep brain stimulation. Stereotact Funct Neurosurg. 2017;95(2):93\u2013101. The paper provides insight in the modulation of the motor circuitry of PD patients by STN-DBS using FDG-PET and the correlations between glucose metabolism and clinical symptoms.","journal-title":"Stereotact Funct Neurosurg"},{"key":"966_CR15","doi-asserted-by":"publisher","first-page":"2667","DOI":"10.1093\/brain\/awl162","volume":"129","author":"K Asanuma","year":"2006","unstructured":"Asanuma K, Tang C, Ma Y, Dhawan V, Mattis P, Edwards C, et al. Network modulation in the treatment of Parkinson\u2019s disease. Brain. 2006;129(Pt 10:2667\u201378.","journal-title":"Brain."},{"issue":"8","key":"966_CR16","doi-asserted-by":"publisher","first-page":"3656","DOI":"10.1172\/JCI75073","volume":"124","author":"JH Ko","year":"2014","unstructured":"Ko JH, Feigin A, Mattis PJ, Tang CC, Ma Y, Dhawan V, et al. Network modulation following sham surgery in Parkinson\u2019s disease. J Clin Invest. 2014;124(8):3656\u201366.","journal-title":"J Clin Invest"},{"issue":"2","key":"966_CR17","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1016\/j.neuroimage.2010.09.028","volume":"54","author":"H Mure","year":"2011","unstructured":"Mure H, Hirano S, Tang CC, Isaias IU, Antonini A, Ma Y, et al. Parkinson\u2019s disease tremor-related metabolic network: characterization, progression, and treatment effects. Neuroimage. 2011;54(2):1244\u201353.","journal-title":"Neuroimage."},{"issue":"8","key":"966_CR18","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.1073\/pnas.1411011112","volume":"112","author":"PG Spetsieris","year":"2015","unstructured":"Spetsieris PG, Ko JH, Tang CC, Nazem A, Sako W, Peng S, et al. Metabolic resting-state brain networks in health and disease. Proc Natl Acad Sci U S A. 2015;112(8):2563\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"966_CR19","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1212\/WNL.0000000000000130","volume":"82","author":"F Holtbernd","year":"2014","unstructured":"Holtbernd F, Gagnon JF, Postuma RB, Ma Y, Tang CC, Feigin A, et al. Abnormal metabolic network activity in REM sleep behavior disorder. Neurology. 2014;82:620\u20137.","journal-title":"Neurology."},{"key":"966_CR20","doi-asserted-by":"publisher","first-page":"3122","DOI":"10.1093\/brain\/awu290","volume":"137","author":"P Wu","year":"2014","unstructured":"Wu P, Yu H, Peng S, Dauvilliers Y, Wang J, Ge J, et al. Consistent abnormalities in metabolic network activity in idiopathic rapid eye movement sleep behaviour disorder. Brain. 2014;137:3122\u20138.","journal-title":"Brain."},{"key":"966_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuint.2019.02.019","volume":"126","author":"S Ztaou","year":"2019","unstructured":"Ztaou S, Amalric M. Contribution of cholinergic interneurons to striatal pathophysiology in Parkinson\u2019s disease. Neurochem Int. 2019;126:1\u201310.","journal-title":"Neurochem Int"},{"issue":"2","key":"966_CR22","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.neuroimage.2006.09.003","volume":"34","author":"C Huang","year":"2007","unstructured":"Huang C, Mattis P, Tang C, Perrine K, Carbon M, Eidelberg D. Metabolic brain networks associated with cognitive function in Parkinson\u2019s disease. Neuroimage. 2007;34(2):714\u201323.","journal-title":"Neuroimage."},{"key":"966_CR23","doi-asserted-by":"publisher","first-page":"2958","DOI":"10.1093\/brain\/awp245","volume":"132","author":"CH Williams-Gray","year":"2009","unstructured":"Williams-Gray CH, Evans JR, Goris A, Foltynie T, Ban M, Robbins TW, et al. The distinct cognitive syndromes of Parkinson\u2019s disease: 5 year follow-up of the CamPaIGN cohort. Brain. 2009;132(Pt 11:2958\u201369.","journal-title":"Brain."},{"issue":"3","key":"966_CR24","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/mds.24893","volume":"27","author":"I Litvan","year":"2012","unstructured":"Litvan I, Goldman JG, Tr\u00f6ster AI, Schmand BA, Weintraub D, Petersen RC, et al. Diagnostic criteria for mild cognitive impairment in Parkinson\u2019s disease: Movement Disorder Society Task Force guidelines. Mov Disord. 2012;27(3):349\u201356.","journal-title":"Mov Disord"},{"issue":"10","key":"966_CR25","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1002\/mds.22662","volume":"24","author":"I Liepelt","year":"2009","unstructured":"Liepelt I, Reimold M, Maetzler W, Godau J, Reischl G, Gaenslen A, et al. Cortical hypometabolism assessed by a metabolic ratio in Parkinson\u2019s disease primarily reflects cognitive deterioration-[18F]FDG-PET. Mov Disord. 2009;24(10):1504\u201311.","journal-title":"Mov Disord"},{"issue":"11","key":"966_CR26","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1007\/s00259-012-2198-5","volume":"39","author":"D Garcia-Garcia","year":"2012","unstructured":"Garcia-Garcia D, Clavero P, Gasca Salas C, Lamet I, Arbizu J, Gonzalez-Redondo R, et al. Posterior parietooccipital hypometabolism may differentiate mild cognitive impairment from dementia in Parkinson\u2019s disease. Eur J Nucl Med Mol Imaging. 2012;39(11):1767\u201377.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"966_CR27","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.1093\/brain\/awu159","volume":"137","author":"R Gonz\u00e1lez-Redondo","year":"2014","unstructured":"Gonz\u00e1lez-Redondo R, Garc\u00eda-Garc\u00eda D, Clavero P, Gasca-Salas C, Garc\u00eda-Eulate R, Zubieta JL, et al. Grey matter hypometabolism and atrophy in Parkinson\u2019s disease with cognitive impairment: a two-step process. Brain. 2014;137(Pt 8:2356\u201367.","journal-title":"Brain."},{"issue":"12","key":"966_CR28","doi-asserted-by":"publisher","first-page":"e1029","DOI":"10.1212\/WNL.0000000000005161","volume":"90","author":"A Pilotto","year":"2018","unstructured":"\u2022\u2022 Pilotto A, Premi E, Paola Caminiti S, Presotto L, Turrone R, Alberici A, et al. Single-subject SPM FDG-PET patterns predict risk of dementia progression in Parkinson disease. Neurology. 2018;90(12):e1029\u201337. The study evaluates FDG-PET imaging as a possible single-subject marker of progression to dementia in PD. At 4-year follow-up, all patients showing atypical brain metabolic patterns at baseline progressed to PD dementia. The DLB- and AD-like SPM patterns were the best predictor for incident dementia with a sensitivity of 85% and a specificity of 88%.","journal-title":"Neurology"},{"issue":"8","key":"966_CR29","doi-asserted-by":"publisher","first-page":"3178","DOI":"10.1002\/hbm.24068","volume":"39","author":"A Verger","year":"2018","unstructured":"Verger A, Klesse E, Chawki MB, Witjas T, Azulay JP, Eusebio A, et al. Brain PET substrate of impulse control disorders in Parkinson\u2019s disease: a metabolic connectivity study. Hum Brain Mapp. 2018;39(8):3178\u201386.","journal-title":"Hum Brain Mapp"},{"issue":"11","key":"966_CR30","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1212\/WNL.0b013e3182698c75","volume":"79","author":"G Robert","year":"2012","unstructured":"Robert G, Le Jeune F, Lozachmeur C, Drapier S, Dondaine T, P\u00e9ron J, et al. Apathy in patients with Parkinson disease without dementia or depression: a PET study. Neurology. 2012;79(11):1155\u201360.","journal-title":"Neurology."},{"issue":"3\u20134","key":"966_CR31","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1159\/000345987","volume":"35","author":"C Huang","year":"2013","unstructured":"Huang C, Ravdin LD, Nirenberg MJ, Piboolnurak P, Severt L, Maniscalco JS, et al. Neuroimaging markers of motor and nonmotor features of Parkinson\u2019s disease: an 18f fluorodeoxyglucose positron emission computed tomography study. Dement Geriatr Cogn Disord. 2013;35(3\u20134):183\u201396.","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"1","key":"966_CR32","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/hbm.23360","volume":"38","author":"SS Cho","year":"2017","unstructured":"Cho SS, Aminian K, Li C, Lang AE, Houle S, Strafella AP. Fatigue in Parkinson\u2019s disease: the contribution of cerebral metabolic changes. Hum Brain Mapp. 2017;38(1):283\u201392.","journal-title":"Hum Brain Mapp"},{"issue":"5","key":"966_CR33","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1002\/mds.21933","volume":"23","author":"T Eckert","year":"2008","unstructured":"Eckert T, Tang C, Ma Y, Brown N, Lin T, Frucht S, et al. Abnormal metabolic networks in atypical parkinsonism. Mov Disord. 2008;23(5):727\u201333.","journal-title":"Mov Disord"},{"issue":"4","key":"966_CR34","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1007\/s00415-014-7256-4","volume":"261","author":"N Zalewski","year":"2014","unstructured":"Zalewski N, Botha H, Whitwell JL, Lowe V, Dickson DW, Josephs KA. FDG-PET in pathologically confirmed spontaneous 4R-tauopathy variants. J Neurol. 2014;261(4):710\u20136.","journal-title":"J Neurol"},{"issue":"1\u20132","key":"966_CR35","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.neulet.2005.03.057","volume":"383","author":"R Juh","year":"2005","unstructured":"Juh R, Pae CU, Kim TS, Lee CU, Choe B, Suh T. Cerebral glucose metabolism in corticobasal degeneration comparison with progressive supranuclear palsy using statistical mapping analysis. Neurosci Lett. 2005;383(1\u20132):22\u20137.","journal-title":"Neurosci Lett"},{"issue":"8","key":"966_CR36","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1097\/MNM.0000000000000320","volume":"36","author":"I Sarikaya","year":"2015","unstructured":"Sarikaya I. PET imaging in neurology: Alzheimer\u2019s and Parkinson\u2019s diseases. Nucl Med Commun. 2015;36(8):775\u201381.","journal-title":"Nucl Med Commun"},{"issue":"3","key":"966_CR37","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/j.neuroimage.2005.03.012","volume":"26","author":"T Eckert","year":"2005","unstructured":"Eckert T, Barnes A, Dhawan V, Frucht S, Gordon MF, Feigin AS, et al. FDG PET in the differential diagnosis of parkinsonian disorders. Neuroimage. 2005;26(3):912\u201321.","journal-title":"Neuroimage."},{"issue":"9","key":"966_CR38","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1007\/s00259-018-4031-2","volume":"45","author":"Z Walker","year":"2018","unstructured":"Walker Z, Gandolfo F, Orini S, Garibotto V, Agosta F, Arbizu J, et al. Clinical utility of FDG PET in Parkinson\u2019s disease and atypical parkinsonism associated with dementia. Eur J Nucl Med Mol Imaging. 2018;45(9):1534\u201345.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"6","key":"966_CR39","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1002\/mds.26987","volume":"32","author":"GU Hoglinger","year":"2017","unstructured":"\u2022 Hoglinger GU, Respondek G, Stamelou M, Kurz C, Josephs KA, Lang AE, et al. Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria. Mov Disord. 2017;32(6):853\u201364. This is a consensus-based revision of the clinical diagnostic criteria for PSP. New criteria consistent of four functional domains as clinical predictors of PSP, combinations of clinical features stratified by degrees of diagnostic certainty, clinical clues, and imaging findings as supportive features are discussed.","journal-title":"Mov Disord"},{"key":"966_CR40","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1007\/s00259-009-1265-z","volume":"37","author":"K Van Laere","year":"2010","unstructured":"Van Laere K, Varrone A, Brooj J. EANM procedure guidelines for brain neurotransmission SPECT\/PET using dopamine D2 receptor ligands, version 2. Eur J Nucl Med Mol Imaging. 2010;37:434\u201342.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"966_CR41","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/1471-2377-7-27","volume":"7","author":"AM Vlaar","year":"2007","unstructured":"Vlaar AM, van Kroonenburgh MJ, Kessels AG, Weber WE. Meta-analysis of the literature on diagnostic accuracy of SPECT in parkinsonian syndromes. BMC Neurol. 2007;7:27.","journal-title":"BMC Neurol"},{"issue":"13","key":"966_CR42","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1212\/WNL.0b013e31826c1b0a","volume":"79","author":"S Hellwig","year":"2012","unstructured":"Hellwig S, Amtage F, Kreft A, Buchert R, Winz OH, Vach W, et al. [18F]FDG-PET is superior to [123I]IBZM-SPECT for the differential diagnosis of parkinsonism. Neurology. 2012;79(13):1314\u201322.","journal-title":"Neurology."},{"issue":"3","key":"966_CR43","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1002\/ana.410200305","volume":"20","author":"AB Young","year":"1986","unstructured":"Young AB, Penney JB, Starosta-Rubinstein S, Markel DS, Berent S, Giordani B, et al. PET scan investigations of Huntington\u2019s disease: cerebral metabolic correlates of neurological features and functional decline. Ann Neurol. 1986;20(3):296\u2013303.","journal-title":"Ann Neurol"},{"key":"966_CR44","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1093\/brain\/113.5.1405","volume":"113","author":"T Kuwert","year":"1990","unstructured":"Kuwert T, Lange HW, Langen KJ, Herzog H, Aulich A, Feinendegen LE. Cortical and subcortical glucose consumption measured by PET in patients with Huntington\u2019s disease. Brain. 1990;113(Pt 5:1405\u201323.","journal-title":"Brain"},{"issue":"Pt 6","key":"966_CR45","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1093\/brain\/119.6.2085","volume":"119","author":"A Antonini","year":"1996","unstructured":"Antonini A, Leenders KL, Spiegel R, Meier D, Vontobel P, Weigell-Weber M, et al. Striatal glucose metabolism and dopamine D2 receptor binding in asymptomatic gene carriers and patients with Huntington\u2019s disease. Brain. 1996;119(Pt 6):2085\u201395.","journal-title":"Brain"},{"key":"966_CR46","first-page":"215","volume":"47","author":"A Ciarmiello","year":"2006","unstructured":"Ciarmiello A, Cannella M, Lastoria S, Simonelli M, Frati L, Rubinsztein DC, et al. Brain white-matter volume loss and glucose hypometabolism precede the clinical symptoms of Huntington\u2019s disease. J Nucl Med. 2006;47:215\u201322.","journal-title":"J Nucl Med"},{"key":"966_CR47","doi-asserted-by":"publisher","first-page":"2858","DOI":"10.1093\/brain\/awm217","volume":"130","author":"A Feigin","year":"2007","unstructured":"Feigin A, Tang C, Ma Y, Mattis P, Zgaljardic D, Guttman M, et al. Thalamic metabolism and symptom onset in preclinical Huntington\u2019s disease. Brain. 2007;130:2858\u201367.","journal-title":"Brain."},{"issue":"9","key":"966_CR48","doi-asserted-by":"publisher","first-page":"4076","DOI":"10.1172\/JCI69411","volume":"123","author":"CC Tang","year":"2013","unstructured":"Tang CC, Feigin A, Ma Y, Habeck C, Paulsen JS, Leenders KL, et al. Metabolic network as a progression biomarker of premanifest Huntington\u2019s disease. J Clin Invest. 2013;123(9):4076\u201388.","journal-title":"J Clin Invest"},{"issue":"2","key":"966_CR49","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.nbd.2011.01.026","volume":"42","author":"VK Neychev","year":"2011","unstructured":"Neychev VK, Gross R, Leh\u00e9ricy S, Hess EJ, Jinnah HA. The functional neuroanatomy of dystonia. Neurobiol Dis. 2011;42(2):185\u2013201.","journal-title":"Neurobiol Dis"},{"issue":"7","key":"966_CR50","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1002\/mds.25527","volume":"28","author":"S Leh\u00e9ricy","year":"2013","unstructured":"Leh\u00e9ricy S, Tijssen MAJ, Vidailhet M, Kaji R, Meunier S. The anatomical basis of dystonia: current view using neuroimaging. Mov Disord. 2013;28(7):944\u201357.","journal-title":"Mov Disord"},{"issue":"5","key":"966_CR51","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1136\/jnnp-2017-316250","volume":"89","author":"R Kaji","year":"2018","unstructured":"\u2022 Kaji R, Bhatia K, Graybiel AM. Pathogenesis of dystonia: is it of cerebellar or basal ganglia origin? J Neurol Neurosurg Psychiatry. 2018;89(5):488\u201392. The paper reviews current evidence on a new functional interaction between the cerebellum and basal ganglia in the pathogenesis of dystonia; highlighting it is now regarded as a \u2018network\u2019 disorder including the cerebellum.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"966_CR52","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1002\/ana.10418","volume":"52","author":"M Trost","year":"2002","unstructured":"Trost M, Carbon M, Edwards C, Ma Y, Raymond D, Mentis MJ, et al. Primary dystonia: is abnormal functional brain architecture linked to genotype? Ann Neurol. 2002;52(6):853\u20136.","journal-title":"Ann Neurol"},{"issue":"1","key":"966_CR53","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.neuroscience.2008.12.041","volume":"164","author":"M Carbon","year":"2009","unstructured":"Carbon M, Eidelberg D. Abnormal structure-function relationships in hereditary dystonia. Neuroscience. 2009;164(1):220\u20139.","journal-title":"Neuroscience"},{"issue":"4","key":"966_CR54","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1212\/WNL.0b013e31827f0798","volume":"80","author":"M Carbon","year":"2013","unstructured":"Carbon M, Raymond D, Ozelius L, Saunders-Pullman R, Frucht S, Dhawan V, et al. Metabolic changes in DYT11 myoclonus-dystonia. Neurology. 2013;80(4):385\u201391.","journal-title":"Neurology"},{"key":"966_CR55","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.nicl.2018.08.006","volume":"20","author":"DC Matthews","year":"2018","unstructured":"\u2022 Matthews DC, Lerman H, Lukic A, Andrews RD, Mirelman A, Wernick MN, et al. FDG PET Parkinson\u2019s disease-related pattern as a biomarker for clinical trials in early stage disease. Neuroimage Clin. 2018;20:572\u20139. The authors present evidence on how FDG-PET using two classifiers can discriminate HC from PD observing very similar metabolic patters, consistent with the PDRP. They propose that FDG-PET and multivariate classification can provide an objective biomarker of disease stage with the potential to detect treatment effects on PD progression.","journal-title":"Neuroimage Clin"},{"key":"966_CR56","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/bs.irn.2018.10.003","volume":"144","author":"G Tondo","year":"2019","unstructured":"Tondo G, Esposito M, Dervenoulas G, Wilson H, Politis M, Pagano G. Hybrid PET-MRI applications in movement disorders. Int Rev Neurobiol. 2019;144:211\u201357.","journal-title":"Int Rev Neurobiol"}],"container-title":["Current Neurology and Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-019-0966-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11910-019-0966-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-019-0966-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,27]],"date-time":"2020-06-27T23:17:44Z","timestamp":1593299864000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11910-019-0966-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,29]]},"references-count":56,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["966"],"URL":"https:\/\/doi.org\/10.1007\/s11910-019-0966-3","relation":{},"ISSN":["1528-4042","1534-6293"],"issn-type":[{"value":"1528-4042","type":"print"},{"value":"1534-6293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,29]]},"assertion":[{"value":"29 June 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Cecilia Peralta, Federico Biafore, Tamara Soto, and Maria Bastianello each declare no potential conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"56"}}